T1	Treatment 23 39	oral conivaptan:
T2	Treatment 42 80	V1A/V2 vasopressin receptor antagonist
T3	Treatment 108 126	placebo-controlled
T4	Treatment 508 569	oral conivaptan, a vasopressin V(1A)/V(2) receptor antagonist
T5	Treatment 662 680	placebo-controlled
T6	Treatment 774 789	Oral conivaptan
T7	Treatment 809 816	placebo
T8	Treatment 1163 1173	conivaptan
T9	Treatment 1278 1286	placebo.
T10	Treatment 1404 1411	placebo
T11	Treatment 1432 1442	conivaptan
T12	Treatment 1479 1489	conivaptan
T13	Treatment 1768 1775	placebo
T14	Treatment 1803 1813	conivaptan
T15	Treatment 1845 1855	conivaptan
T16	Treatment 1994 2001	placebo
T17	Treatment 2021 2031	conivaptan
T18	Treatment 2055 2065	conivaptan
T19	Treatment 2197 2212	Oral conivaptan
